Mansour Al‐Janadi

509 total citations
20 papers, 418 citations indexed

About

Mansour Al‐Janadi is a scholar working on Immunology, Rheumatology and Epidemiology. According to data from OpenAlex, Mansour Al‐Janadi has authored 20 papers receiving a total of 418 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 6 papers in Rheumatology and 5 papers in Epidemiology. Recurrent topics in Mansour Al‐Janadi's work include T-cell and B-cell Immunology (6 papers), Immune Cell Function and Interaction (5 papers) and Systemic Lupus Erythematosus Research (5 papers). Mansour Al‐Janadi is often cited by papers focused on T-cell and B-cell Immunology (6 papers), Immune Cell Function and Interaction (5 papers) and Systemic Lupus Erythematosus Research (5 papers). Mansour Al‐Janadi collaborates with scholars based in Saudi Arabia and Canada. Mansour Al‐Janadi's co-authors include Syed Raziuddin, Abdullah Al-Dalaan, Jacob Karsh, C. Douglas Smith, Suliman R. Al-Balla, Sultan Bahabri, Saeed Abu‐Eshy, Saeed Bohlega, Abdulwahab Telmesani and Fahad Al-Hameed and has published in prestigious journals such as Cancer, The American Journal of Medicine and Journal of Allergy and Clinical Immunology.

In The Last Decade

Mansour Al‐Janadi

20 papers receiving 399 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mansour Al‐Janadi Saudi Arabia 11 186 140 135 56 38 20 418
Bettina M. Prinz Vavricka Switzerland 5 94 0.5× 94 0.7× 278 2.1× 40 0.7× 40 1.1× 6 692
R.L. Dawkins Australia 16 297 1.6× 102 0.7× 78 0.6× 57 1.0× 41 1.1× 37 579
Irena Litinsky Israel 12 243 1.3× 372 2.7× 121 0.9× 41 0.7× 38 1.0× 21 651
De Vos M Belgium 10 168 0.9× 373 2.7× 162 1.2× 17 0.3× 40 1.1× 18 580
Anabel Aron-Maor Israel 8 267 1.4× 230 1.6× 152 1.1× 22 0.4× 43 1.1× 8 553
Nurith Vardinon Israel 13 121 0.7× 111 0.8× 92 0.7× 80 1.4× 56 1.5× 40 495
P Dujardin France 11 58 0.3× 75 0.5× 109 0.8× 42 0.8× 61 1.6× 101 443
H. Rodrigues Brazil 12 122 0.7× 66 0.5× 45 0.3× 25 0.4× 42 1.1× 37 408
Evanthia Zampeli Greece 9 127 0.7× 47 0.3× 140 1.0× 43 0.8× 47 1.2× 26 379
N Iida Japan 14 186 1.0× 217 1.6× 112 0.8× 44 0.8× 28 0.7× 33 487

Countries citing papers authored by Mansour Al‐Janadi

Since Specialization
Citations

This map shows the geographic impact of Mansour Al‐Janadi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mansour Al‐Janadi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mansour Al‐Janadi more than expected).

Fields of papers citing papers by Mansour Al‐Janadi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mansour Al‐Janadi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mansour Al‐Janadi. The network helps show where Mansour Al‐Janadi may publish in the future.

Co-authorship network of co-authors of Mansour Al‐Janadi

This figure shows the co-authorship network connecting the top 25 collaborators of Mansour Al‐Janadi. A scholar is included among the top collaborators of Mansour Al‐Janadi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mansour Al‐Janadi. Mansour Al‐Janadi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Al-Hameed, Fahad, et al.. (2016). A project to reduce the rate of central line associated bloodstream infection in ICU patients to a target of zero. BMJ Quality Improvement Reports. 5(1). u212545.w4986–u212545.w4986. 15 indexed citations
2.
Obeid, Tahir, et al.. (2009). Epilepsy in patients 60 years and above.. PubMed. 14(1). 53–5. 6 indexed citations
3.
Raziuddin, Syed, et al.. (1998). Regulation of interleukin‐4 production and cytokine‐induced growth potential in peripheral T‐cell non‐Hodgkin's lymphomas. British Journal of Haematology. 100(2). 310–316. 5 indexed citations
4.
Al‐Janadi, Mansour, et al.. (1996). Interleukin-10 (IL-10) secretion in systemic lupus erythematosus and rheumatoid arthritis: IL-10-dependent CD4+CD45RO+ T cell-B cell antibody synthesis. Journal of Clinical Immunology. 16(4). 198–207. 50 indexed citations
5.
Raziuddin, Syed, et al.. (1995). CD4+ Th2 cell response cytokine production in bacterial meningitis. Journal of Clinical Immunology. 15(6). 338–348. 10 indexed citations
6.
Raziuddin, Syed, et al.. (1994). γδ T lymphocytes and proinflammatory cytokines in bacterial meningitis. Journal of Allergy and Clinical Immunology. 93(4). 793–798. 24 indexed citations
7.
Raziuddin, Syed, et al.. (1994). Circulating levels of cytokines and soluble cytokine receptors in various T-cell malignancies. Cancer. 73(9). 2426–2431. 18 indexed citations
8.
Al‐Janadi, Mansour, et al.. (1994). PERIPHERAL T-CELL LYMPHOMAS - CYTOKINE PROFILE AND CHARACTERISTIC INTERLEUKIN-4 AND TUMOR-NECROSIS-FACTOR ALPHA-DEFICIENCY. International Journal of Oncology. 4(1). 91–5. 1 indexed citations
9.
Al‐Janadi, Mansour & Syed Raziuddin. (1993). B cell hyperactivity is a function of T cell derived cytokines in systemic lupus erythematosus.. PubMed. 20(11). 1885–91. 26 indexed citations
10.
Al‐Janadi, Mansour, et al.. (1993). Cytokine profile of viral and autoimmune chronic active hepatitis. Journal of Allergy and Clinical Immunology. 92(6). 902–908. 43 indexed citations
11.
Al‐Janadi, Mansour, et al.. (1993). Peripheral T-cell lymphoma with unique immunologic features. Cancer. 71(3). 831–838. 4 indexed citations
12.
Al-Dalaan, Abdullah, et al.. (1993). Association of anti-cardiolipin antibodies with vascular thrombosis and neurological manifestation of Behçets disease. Clinical Rheumatology. 12(1). 28–30. 29 indexed citations
13.
Al‐Janadi, Mansour, Suliman R. Al-Balla, Abdullah Al-Dalaan, & Syed Raziuddin. (1993). Cytokine production by helper T cell populations from the synovial fluid and blood in patients with rheumatoid arthritis.. PubMed. 20(10). 1647–53. 20 indexed citations
14.
Al‐Janadi, Mansour, et al.. (1993). Visceral leishmaniasis: II. Histiocyte ultrastructure in bone marrow associated with low level of parasitaemia and mimicking malignant histiocytosis.. PubMed. 34(4). 259–64. 1 indexed citations
15.
Al‐Janadi, Mansour, et al.. (1993). VISCERAL LEISHMANIASIS WITH A VERY-LOW DEGREE OF BONE-MARROW PARASITEMIA, MIMICKING MALIGNANT HISTIOCYTOSIS. International Journal of Oncology. 3(3). 477–480. 6 indexed citations
16.
Al-Dalaan, Abdullah, et al.. (1993). Pattern of Adult Onset of Polymyositis and Dermatomyositis and Association with Malignancy. Annals of Saudi Medicine. 13(6). 525–529. 7 indexed citations
17.
Raziuddin, Syed, et al.. (1992). T-cell receptor α/β chain-CD3 protein complex defect in systemic lupus erythematosus: T-cell function. The American Journal of Medicine. 93(4). 461–466. 7 indexed citations
18.
Raziuddin, Syed, et al.. (1992). γδ T cells and the immune response in visceral leishmaniasis. European Journal of Immunology. 22(5). 1143–1148. 61 indexed citations
19.
Raziuddin, Syed, et al.. (1991). Soluble interleukin 2 receptor levels in serum and its relationship to T cell abnormality and clinical manifestations of the disease in patients with systemic lupus erythematosus.. PubMed. 18(6). 831–6. 20 indexed citations
20.
Al‐Janadi, Mansour, C. Douglas Smith, & Jacob Karsh. (1989). Cyclophosphamide treatment of interstitial pulmonary fibrosis in polymyositis/dermatomyositis.. PubMed. 16(12). 1592–6. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026